E-Newsletter - September 2022
Alliance Patient Advocate Committee
Alliance WELCOMES THREE NEW PATIENT ADVOCATES
Bringing a wealth of diverse experiences - ranging from industry partner to world traveler to nursing - is what three remarkable and accomplished individuals will do for the Alliance Patient Advocate Committee this fall. Alliance welcomes these new members as the committee expands to further facilitate the patient perspective throughout all Alliance scientific, modality, and administrative committees.
Todd Kennedy, of Orange County, California, brings experience and perspective to the committee as a healthcare business professional, myeloma patient, and advocate. Retired in 2020 from a career in the pharma industry, Mr. Kennedy has redirected his focus towards patient advocacy with the goal of leveraging his professional and personal experience to support key stakeholders that are best positioned to accelerate cancer research and enhance patient access. He has developed diverse patient insights through active 1-to-1 coaching of myeloma patients and by co-leading a monthly support group of more than 700 members. Mr. Kennedy will serve on the Alliance Cancer Care Delivery Research Committee.
Kelly Shanahan, of South Lake Tahoe, California, had everything going for her: a successful ob-gyn practice; a precocious nine-year-old daughter; and a well-used passport from traveling all over the world with her family to attend conferences, with a libel dose of vacation on the side. When she was diagnosed with stage IIB breast cancer, Ms. Shanahan considered it a mere bump in the road; she returned to work two weeks after her bilateral mastectomy and continued to work all through the four months of chemo. Fast forward five years later, her cancer returned with a vengeance and its side effects did cost her her career, but she found a new purpose in advocacy. Ms. Shanahan will serve on the Alliance Symptom Intervention Committee.
Stephanie Walker, of Tarboro, North Carolina, stays busy advocating for men and women in rural areas, including the area she lives in, and for equal access to quality healthcare, treatment modalities, and resources. She is a metastatic breast cancer survivor and registered nurse with nearly 40 years of clinical practice and secondary teaching experience. The last 15 years of nursing she has worked in hospice, end of life, care. Her advocacy has come largely since 2018 when she attended her first national breast cancer event, Living Beyond Breast Cancer’s Conference on Metastatic Breast Cancer. Ms. Walker will serve on the Alliance Symptom Intervention Committee.
Read more articles in this month's e-newsletter:
- Alliance Leadership Transition: Suzanne George, MD, Appointed Interim Group Chair
- Alliance Welcomes Three New Patient Advocates
-
October is National Breast Cancer Awareness Month
A011801 (COMPASS HER2 RD/Breast Cancer)
A071701 (Genomically-guided Treatment in Brain Metastases)
A191901 (Optimizing Endocrine Therapy)
A221803 (Reducing Radiation Dermatitis)
A231910CD (Patient-centered Communication in Breast Cancer) -
Spotlight on Alliance Trials
*Recently Activated Trials
A212102 (Multicancer Early Detection Blood Tests)
A032101 (Metastatic Hormone-sensitive Prostate Cancer)
*Ongoing Trials
A032002 (Metastatic Urothelial Cancer)
A051902 (Peripheral T-cell Lymphoma)
A081801 (Resected Non-small Cell Lung Cancer)
A222001 (Hot Flashes in Men/Androgen Deprivation Therapy) -
Announcements
Registration Now Open: 2022 Alliance Fall Hybrid Group Meeting
Call for Applications: Alliance CRP Committee Cadre Members
Call for Proposals: Alliance Cancer Control Program Pilot Awards -
Alliance in the News
Alliance for Clinical Trials in Oncology Applauds Appointment of Monica M. Bertagnolli as NCI's New Director
Interview with Patient on Alliance RadiCaL Study (A031801)
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
Novel Drug Delivery Systems for Patients With Advanced Prostate Cancer: A Focus on Radioligand Therapy and ADCs
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated with Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)
Preoperative Combination Chemotherapy Improved Survival in Patients with Pancreatic Cancer
Alliance Foundation Trials Study Finds Combination Hormonal Therapy Delivered in Finite Period Improves PSA Levels in Patients with Prostate Cancer
Alliance MCED Biobank Study May Provide Greater Understanding of How to Detect Multiple Cancers